Cochrane Abstracts
Marine‐derived n‐3 fatty acids therapy for stroke
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Marine‐derived N‐3 Fatty Acids Therapy for Stroke." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435815/all/Marine‐derived_n‐3_fatty_acids_therapy_for_stroke.
Marine‐derived n‐3 fatty acids therapy for stroke. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435815/all/Marine‐derived_n‐3_fatty_acids_therapy_for_stroke. Accessed March 15, 2025.
Marine‐derived n‐3 fatty acids therapy for stroke. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435815/all/Marine‐derived_n‐3_fatty_acids_therapy_for_stroke
Marine‐derived N‐3 Fatty Acids Therapy for Stroke [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 15]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435815/all/Marine‐derived_n‐3_fatty_acids_therapy_for_stroke.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Marine‐derived n‐3 fatty acids therapy for stroke
ID - 435815
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435815/all/Marine‐derived_n‐3_fatty_acids_therapy_for_stroke
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
